Published in J Immunol on November 01, 2007
The role of the anaphylatoxins in health and disease. Mol Immunol (2009) 2.95
Locally produced C5a binds to T cell-expressed C5aR to enhance effector T-cell expansion by limiting antigen-induced apoptosis. Blood (2008) 2.91
Complement 5a receptor inhibition improves renal allograft survival. J Am Soc Nephrol (2008) 1.72
Immune cell-derived c3 is required for autoimmune diabetes induced by multiple low doses of streptozotocin. Diabetes (2010) 1.57
Signaling through C5a receptor and C3a receptor diminishes function of murine natural regulatory T cells. J Exp Med (2013) 1.48
C5a receptor-deficient dendritic cells promote induction of Treg and Th17 cells. Eur J Immunol (2010) 1.34
Complement System Part II: Role in Immunity. Front Immunol (2015) 1.31
Donor deficiency of decay-accelerating factor accelerates murine T cell-mediated cardiac allograft rejection. J Immunol (2008) 1.28
Antigen-presenting cell-derived complement modulates graft-versus-host disease. J Clin Invest (2012) 1.09
Nucleic acids and endosomal pattern recognition: how to tell friend from foe? Front Cell Infect Microbiol (2013) 1.04
Mechanisms of complement activation, C4d deposition, and their contribution to the pathogenesis of antibody-mediated rejection. Transplant Rev (Orlando) (2009) 1.03
Role of DAF in protecting against T-cell autoreactivity that leads to experimental autoimmune uveitis. Invest Ophthalmol Vis Sci (2009) 0.97
Role and mechanism of action of complement in regulating T cell immunity. Mol Immunol (2010) 0.97
Pharmacological targeting of C5a receptors during organ preservation improves kidney graft survival. Clin Exp Immunol (2008) 0.95
Complement regulation of T cell immunity. Immunol Res (2012) 0.95
Complement gene expression in human cardiac allograft biopsies as a correlate of histologic grade of injury. Transplantation (2008) 0.93
Complement regulates CD4 T-cell help to CD8 T cells required for murine allograft rejection. Am J Pathol (2011) 0.93
Upregulated expression of complement inhibitory proteins on bladder cancer cells and anti-MUC1 antibody immune selection. Int J Cancer (2008) 0.92
Modulation of protective T cell immunity by complement inhibitor expression on tumor cells. Cancer Res (2008) 0.90
Anti-complement component C5 mAb synergizes with CTLA4Ig to inhibit alloreactive T cells and prolong cardiac allograft survival in mice. Am J Transplant (2011) 0.90
Complement as a multifaceted modulator of kidney transplant injury. J Clin Invest (2014) 0.89
C5aR expression in a novel GFP reporter gene knockin mouse: implications for the mechanism of action of C5aR signaling in T cell immunity. J Immunol (2012) 0.89
NOD2-mediated suppression of CD55 on neutrophils enhances C5a generation during polymicrobial sepsis. PLoS Pathog (2013) 0.89
The complement inhibitor FUT-175 suppresses T cell autoreactivity in experimental autoimmune encephalomyelitis. Am J Pathol (2009) 0.88
Decay accelerating factor is essential for successful corneal engraftment. Am J Transplant (2010) 0.87
Evolving paradigms that determine the fate of an allograft. Am J Transplant (2010) 0.86
Retinal pericytes inhibit activated T cell proliferation. Invest Ophthalmol Vis Sci (2011) 0.86
Decay-accelerating factor 1 (Daf1) deficiency exacerbates xenobiotic-induced autoimmunity. Immunology (2010) 0.85
The innate immune system in transplantation. Semin Immunol (2011) 0.84
Decay-accelerating factor 1 deficiency exacerbates leptospiral-induced murine chronic nephritis and renal fibrosis. PLoS One (2014) 0.84
The "ins and outs" of complement-driven immune responses. Immunol Rev (2016) 0.84
Increased morbidity and mortality in murine cytomegalovirus-infected mice following allogeneic bone marrow transplant is associated with reduced surface decay accelerating factor expression. Clin Exp Immunol (2010) 0.82
Decay-accelerating factor regulates T-cell immunity in the context of inflammation by influencing costimulatory molecule expression on antigen-presenting cells. Blood (2011) 0.82
Reduced graft-versus-host disease in C3-deficient mice is associated with decreased donor Th1/Th17 differentiation. Biol Blood Marrow Transplant (2012) 0.81
Complement regulation of T-cell alloimmunity. Semin Nephrol (2013) 0.81
Augmenting DAF levels in vivo ameliorates experimental autoimmune encephalomyelitis. Mol Immunol (2009) 0.80
IL-12 and related cytokines: function and regulatory implications in Candida albicans infection. Clin Dev Immunol (2010) 0.78
Renal C3 complement component: feed forward to diabetic kidney disease. Am J Nephrol (2015) 0.78
Complement regulation of T-cell alloimmunity. Curr Opin Organ Transplant (2011) 0.78
Dysregulation of complement system and CD4+ T cell activation pathways implicated in allergic response. PLoS One (2013) 0.77
A complement a day keeps the Fox(p3) away. Nat Immunol (2013) 0.77
Late stage definitive endodermal differentiation can be defined by Daf1 expression. BMC Dev Biol (2016) 0.75
Intranasal peptide-induced tolerance and linked suppression: consequences of complement deficiency. Immunology (2015) 0.75
Complement in Kidney Transplantation. Front Med (Lausanne) (2017) 0.75
TLR-Induced Murine Dendritic Cell (DC) Activation Requires DC-Intrinsic Complement. J Immunol (2017) 0.75
Reciprocal expression of interferon gamma or interleukin 4 during the resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T cell subsets. J Exp Med (1989) 11.36
Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu Rev Immunol (1995) 10.65
B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy. Cell (1995) 6.88
IL-12-deficient mice are defective in IFN gamma production and type 1 cytokine responses. Immunity (1996) 6.16
Inhibition of complement activation on the surface of cells after incorporation of decay-accelerating factor (DAF) into their membranes. J Exp Med (1984) 5.47
Role of C5a in inflammatory responses. Annu Rev Immunol (2005) 4.38
The effect of antigen dose on CD4+ T helper cell phenotype development in a T cell receptor-alpha beta-transgenic model. J Exp Med (1995) 4.21
Identification of complement factor 5 as a susceptibility locus for experimental allergic asthma. Nat Immunol (2000) 4.02
Extent of T cell receptor ligation can determine the functional differentiation of naive CD4+ T cells. J Exp Med (1995) 3.98
Antigen-specific development of primary and memory T cells in vivo. Science (1995) 3.41
Local synthesis of complement component C3 regulates acute renal transplant rejection. Nat Med (2002) 3.39
T cell genetic background determines default T helper phenotype development in vitro. J Exp Med (1995) 3.18
Gamma chain required for naïve CD4+ T cell survival but not for antigen proliferation. Nat Immunol (2000) 3.10
Genetically resistant mice lacking interleukin-12 are susceptible to infection with Leishmania major and mount a polarized Th2 cell response. Eur J Immunol (1996) 2.76
CD4 cells can be more efficient at tumor rejection than CD8 cells. Blood (2007) 2.68
Complement component C3 promotes T-cell priming and lung migration to control acute influenza virus infection. Nat Med (2002) 2.54
Regulation of the B cell response to T-dependent antigens by classical pathway complement. J Immunol (1996) 2.51
Decay-accelerating factor modulates induction of T cell immunity. J Exp Med (2005) 2.34
C5a negatively regulates toll-like receptor 4-induced immune responses. Immunity (2005) 2.24
A regulatory role for the C5a anaphylatoxin in type 2 immunity in asthma. J Clin Invest (2006) 2.15
The complement inhibitory protein DAF (CD55) suppresses T cell immunity in vivo. J Exp Med (2005) 2.09
Cellular and humoral immunity to Leishmania major in genetically susceptible mice after in vivo depletion of L3T4+ T cells. J Immunol (1987) 1.86
Tissue distribution of products of the mouse decay-accelerating factor (DAF) genes. Exploitation of a Daf1 knock-out mouse and site-specific monoclonal antibodies. Immunology (2001) 1.79
Dendritic cell synthesis of C3 is required for full T cell activation and development of a Th1 phenotype. J Immunol (2006) 1.57
Complement component 3 is required for optimal expansion of CD8 T cells during a systemic viral infection. J Immunol (2003) 1.56
In vivo helper functions of alloreactive memory CD4+ T cells remain intact despite donor-specific transfusion and anti-CD40 ligand therapy. J Immunol (2004) 1.45
Regulatory role of C5a in LPS-induced IL-6 production by neutrophils during sepsis. FASEB J (2003) 1.42
Selective suppression of IL-12 production by chemoattractants. J Immunol (2000) 1.37
Attenuation of experimental autoimmune demyelination in complement-deficient mice. J Immunol (2000) 1.37
Complement C5a receptor is essential for the optimal generation of antiviral CD8+ T cell responses. J Immunol (2004) 1.36
The anaphylatoxins bridge innate and adaptive immune responses in allergic asthma. Mol Immunol (2004) 1.35
G(i)-protein-dependent inhibition of IL-12 production is mediated by activation of the phosphatidylinositol 3-kinase-protein 3 kinase B/Akt pathway and JNK. J Immunol (2005) 1.28
Lymphoid sequestration of alloreactive memory CD4 T cells promotes cardiac allograft survival. J Immunol (2006) 1.23
The alternative activation pathway and complement component C3 are critical for a protective immune response against Pseudomonas aeruginosa in a murine model of pneumonia. Infect Immun (2004) 1.21
The allogeneic T and B cell response is strongly dependent on complement components C3 and C4. Transplantation (2001) 1.20
Macrophages from C3-deficient mice have impaired potency to stimulate alloreactive T cells. Blood (2005) 1.19
IL-12 gene-deficient C57BL/6 mice are susceptible to Leishmania donovani but have diminished hepatic immunopathology. Eur J Immunol (2000) 1.17
Differential role for p38 mitogen-activated protein kinase in regulating CD40-induced gene expression in dendritic cells and B cells. J Immunol (1999) 1.16
Complement regulates inhalation tolerance at the dendritic cell/T cell interface. Mol Immunol (2006) 1.14
Normal polymorphic variations and transcription of the decay accelerating factor gene in paroxysmal nocturnal hemoglobinuria cells. Proc Natl Acad Sci U S A (1988) 1.14
A further link between innate and adaptive immunity: C3 deposition on antigen-presenting cells enhances the proliferation of antigen-specific T cells. Int Immunol (1998) 1.14
Complement defense mechanisms. Curr Opin Immunol (1993) 1.09
The male minor transplantation antigen preferentially activates recipient CD4+ T cells through the indirect presentation pathway in vivo. J Immunol (2003) 1.09
C5a suppresses the production of IL-12 by IFN-gamma-primed and lipopolysaccharide-challenged human monocytes. J Immunol (1999) 1.07
Effect of complement component C3 deficiency on experimental Lyme borreliosis in mice. Infect Immun (2003) 1.02
Stimulation of dendritic cells via CD40 enhances immune responses to Mycobacterium tuberculosis infection. Infect Immun (2001) 1.02
Acute rejection in the absence of cognate recognition of allograft by T cells. J Immunol (2001) 1.00
Structural and functional characterization of a novel T cell receptor co-regulatory protein complex, CD97-CD55. J Biol Chem (2007) 0.99
Anaphylatoxin C5a induces monocyte recruitment and differentiation into dendritic cells by TNF-alpha and prostaglandin E2-dependent mechanisms. J Immunol (2003) 0.94
Costimulation via CD55 on human CD4+ T cells mediated by CD97. J Immunol (2006) 0.94
Distinct regulation of CD40-mediated interleukin-6 and interleukin-12 productions via mitogen-activated protein kinase and nuclear factor kappaB-inducing kinase in mature dendritic cells. Immunology (2006) 0.92
Role of dendritic cell synthesis of complement in the allospecific T cell response. Mol Immunol (2006) 0.90
cis and trans elements differ among mouse strains with high and low extrahepatic complement factor B gene expression. J Exp Med (1992) 0.88
Antigen location contributes to the pathological features of a transplanted heart graft. Am J Pathol (2004) 0.85
Reduced expression of decay-accelerating factor 1 on CD4+ T cells in murine systemic autoimmune disease. Arthritis Rheum (2007) 0.85
IL-12Rbeta2-deficient mice of a genetically resistant background are susceptible to Leishmania major infection and develop a parasite-specific Th2 immune response. Microbes Infect (2003) 0.81
Urinary-cell mRNA profile and acute cellular rejection in kidney allografts. N Engl J Med (2013) 7.40
Racial differences in incident heart failure among young adults. N Engl J Med (2009) 5.60
Glycemic effects of postmenopausal hormone therapy: the Heart and Estrogen/progestin Replacement Study. A randomized, double-blind, placebo-controlled trial. Ann Intern Med (2003) 5.38
Racial differences in the progression from chronic renal insufficiency to end-stage renal disease in the United States. J Am Soc Nephrol (2003) 4.28
Conversion of Bcl-2 from protector to killer by interaction with nuclear orphan receptor Nur77/TR3. Cell (2004) 4.00
The sensitivity and specificity of a simple test to distinguish between urge and stress urinary incontinence. Ann Intern Med (2006) 3.93
Locally produced complement fragments C5a and C3a provide both costimulatory and survival signals to naive CD4+ T cells. Immunity (2008) 3.36
Phenotypic predictors of response to simvastatin therapy among African-Americans and Caucasians: the Cholesterol and Pharmacogenetics (CAP) Study. Am J Cardiol (2006) 2.94
Locally produced C5a binds to T cell-expressed C5aR to enhance effector T-cell expansion by limiting antigen-induced apoptosis. Blood (2008) 2.91
Determination of oestrogen-receptor status and ERBB2 status of breast carcinoma: a gene-expression profiling study. Lancet Oncol (2007) 2.90
Endoscopic and surgical treatments for achalasia: a systematic review and meta-analysis. Ann Surg (2009) 2.89
The incidence of end-stage renal disease is increasing faster than the prevalence of chronic renal insufficiency. Ann Intern Med (2004) 2.86
An HMM approach to genome-wide identification of differential histone modification sites from ChIP-seq data. Bioinformatics (2008) 2.85
A signal-noise model for significance analysis of ChIP-seq with negative control. Bioinformatics (2010) 2.66
A randomized comparison of total or supracervical hysterectomy: surgical complications and clinical outcomes. Obstet Gynecol (2003) 2.57
Serum lipoprotein levels, statin use, and cognitive function in older women. Arch Neurol (2002) 2.41
Nonoptimal lipids commonly present in young adults and coronary calcium later in life: the CARDIA (Coronary Artery Risk Development in Young Adults) study. Ann Intern Med (2010) 2.37
Decay-accelerating factor modulates induction of T cell immunity. J Exp Med (2005) 2.34
Cross-primed CD8(+) T cells mediate graft rejection via a distinct effector pathway. Nat Immunol (2002) 2.25
Primed allospecific T cells prevent the effects of costimulatory blockade on prolonged cardiac allograft survival in mice. Am J Transplant (2002) 2.18
Association between marijuana exposure and pulmonary function over 20 years. JAMA (2012) 2.09
Hot flushes, coronary heart disease, and hormone therapy in postmenopausal women. Menopause (2009) 2.07
Effect of postmenopausal hormone therapy on cognitive function: the Heart and Estrogen/progestin Replacement Study. Am J Med (2002) 2.02
Effect of hysterectomy vs medical treatment on health-related quality of life and sexual functioning: the medicine or surgery (Ms) randomized trial. JAMA (2004) 1.97
Donor Toll-like receptor 4 contributes to ischemia and reperfusion injury following human kidney transplantation. Proc Natl Acad Sci U S A (2009) 1.95
Postmenopausal hormone therapy: does it cause incontinence? Obstet Gynecol (2005) 1.94
Control of hypertension in adults with chronic kidney disease in the United States. Hypertension (2005) 1.92
Mitogenic effect of orphan receptor TR3 and its regulation by MEKK1 in lung cancer cells. Mol Cell Biol (2003) 1.78
Pretransplant CSF-1 therapy expands recipient macrophages and ameliorates GVHD after allogeneic hematopoietic cell transplantation. J Exp Med (2011) 1.78
Predictors of heart failure among women with coronary disease. Circulation (2004) 1.74
Absence of signaling into CD4⁺ cells via C3aR and C5aR enables autoinductive TGF-β1 signaling and induction of Foxp3⁺ regulatory T cells. Nat Immunol (2012) 1.74
T cells primed by Leishmania major infection cross-react with alloantigens and alter the course of allograft rejection. J Immunol (2002) 1.73
Prevalence and risk factors for urinary incontinence in women with type 2 diabetes and impaired fasting glucose: findings from the National Health and Nutrition Examination Survey (NHANES) 2001-2002. Diabetes Care (2006) 1.71
A short Nur77-derived peptide converts Bcl-2 from a protector to a killer. Cancer Cell (2008) 1.66
The expression of CRM1 is associated with prognosis in human osteosarcoma. Oncol Rep (2009) 1.64
Pre-transplant IFN-gamma ELISPOTs are associated with post-transplant renal function in African American renal transplant recipients. Am J Transplant (2005) 1.60
An early complement-dependent and TLR-4-independent phase in the pathogenesis of ethanol-induced liver injury in mice. Hepatology (2009) 1.60
Association of TGFBR2 polymorphism with risk of sudden cardiac arrest in patients with coronary artery disease. Heart Rhythm (2009) 1.59
CD8 T cells can reject major histocompatibility complex class I-deficient skin allografts. Am J Transplant (2004) 1.57
Menopausal symptoms in older women and the effects of treatment with hormone therapy. Obstet Gynecol (2002) 1.57
Immune cell-derived c3 is required for autoimmune diabetes induced by multiple low doses of streptozotocin. Diabetes (2010) 1.57
Common beta-adrenergic receptor polymorphisms are not associated with risk of sudden cardiac death in patients with coronary artery disease. Heart Rhythm (2008) 1.56
The "costs" of urinary incontinence for women. Obstet Gynecol (2006) 1.52
Hysterectomy versus expanded medical treatment for abnormal uterine bleeding: clinical outcomes in the medicine or surgery trial. Obstet Gynecol (2004) 1.52
Pretransplant cellular alloimmunity as assessed by a panel of reactive T cells assay correlates with acute renal graft rejection. Transplantation (2007) 1.50
Signaling through C5a receptor and C3a receptor diminishes function of murine natural regulatory T cells. J Exp Med (2013) 1.48
Clinical significance of postvoid residual volume in older ambulatory women. J Am Geriatr Soc (2011) 1.48
Incarceration, incident hypertension, and access to health care: findings from the coronary artery risk development in young adults (CARDIA) study. Arch Intern Med (2009) 1.47
An eigenfunction method for reconstruction of large-scale and high-contrast objects. IEEE Trans Ultrason Ferroelectr Freq Control (2007) 1.47
Enzyme linked immunosorbent spot (ELISPOT) assay for interferon-gamma independently predicts renal function in kidney transplant recipients. Am J Transplant (2003) 1.47
Biosensors from conjugated polyelectrolyte complexes. Proc Natl Acad Sci U S A (2001) 1.46
IFN-gamma and IL-17 production in experimental autoimmune encephalomyelitis depends on local APC-T cell complement production. J Immunol (2008) 1.45
In vivo helper functions of alloreactive memory CD4+ T cells remain intact despite donor-specific transfusion and anti-CD40 ligand therapy. J Immunol (2004) 1.45
Biomarkers to predict recurrent cardiovascular disease: the Heart and Soul Study. Am J Med (2008) 1.45
Effect of ultra-low-dose transdermal estradiol on breast density in postmenopausal women. Menopause (2007) 1.44
Hepatic stellate cells regulate immune response by way of induction of myeloid suppressor cells in mice. Hepatology (2011) 1.44
Retinoid X receptor regulates Nur77/TR3-dependent apoptosis [corrected] by modulating its nuclear export and mitochondrial targeting. Mol Cell Biol (2004) 1.40
Evolution of the enzyme-linked immunosorbent spot assay for post-transplant alloreactivity as a potentially useful immune monitoring tool. Am J Transplant (2002) 1.38
Decay-accelerating factor deficiency increases susceptibility to dextran sulfate sodium-induced colitis: role for complement in inflammatory bowel disease. J Immunol (2004) 1.38
Generalized Detectability for Discrete Event Systems. Syst Control Lett (2011) 1.38
An atomic resolution model for assembly, architecture, and function of the Dr adhesins. Mol Cell (2004) 1.37
The NF-kappaB p50:p50:HDAC-1 repressor complex orchestrates transcriptional inhibition of multiple pro-inflammatory genes. J Hepatol (2010) 1.37
Panel of reactive T cells as a measurement of primed cellular alloimmunity in kidney transplant candidates. J Am Soc Nephrol (2005) 1.37
Statin therapy, cardiovascular events, and total mortality in the Heart and Estrogen/Progestin Replacement Study (HERS). Circulation (2002) 1.34
Lipid protein interactions: the assembly of CD1d1 with cellular phospholipids occurs in the endoplasmic reticulum. J Immunol (2002) 1.33
Alloreactive T cell responses and acute rejection of single class II MHC-disparate heart allografts are under strict regulation by CD4+ CD25+ T cells. J Immunol (2005) 1.32
A high-density intervarietal map of the wheat genome enriched with markers derived from expressed sequence tags. Theor Appl Genet (2008) 1.31
Markedly enhanced susceptibility to experimental autoimmune myasthenia gravis in the absence of decay-accelerating factor protection. J Clin Invest (2002) 1.31
Incidence and risk of denosumab-related hypocalcemia in cancer patients: a systematic review and pooled analysis of randomized controlled studies. Curr Med Res Opin (2013) 1.29
Donor deficiency of decay-accelerating factor accelerates murine T cell-mediated cardiac allograft rejection. J Immunol (2008) 1.28
Decay-accelerating factor confers protection against complement-mediated podocyte injury in acute nephrotoxic nephritis. Lab Invest (2002) 1.28
Factors associated with weight loss after gastric bypass. Arch Surg (2008) 1.26
Establishment of the first World Health Organization International Genetic Reference Panel for quantitation of BCR-ABL mRNA. Blood (2010) 1.26
Stress urinary incontinence surgery in the United States. Obstet Gynecol (2003) 1.25
Lymphoid sequestration of alloreactive memory CD4 T cells promotes cardiac allograft survival. J Immunol (2006) 1.23
Hostility predicts recurrent events among postmenopausal women with coronary heart disease. Am J Epidemiol (2002) 1.23
Essential helix interactions in the anion transporter domain of prestin revealed by evolutionary trace analysis. J Neurosci (2006) 1.22
Alloreactivity in renal transplant recipients with and without chronic allograft nephropathy. J Am Soc Nephrol (2004) 1.22
Decay-accelerating factor (DAF), complement receptor 1 (CR1), and factor H dissociate the complement AP C3 convertase (C3bBb) via sites on the type A domain of Bb. J Biol Chem (2001) 1.22
Structure of decay-accelerating factor bound to echovirus 7: a virus-receptor complex. Proc Natl Acad Sci U S A (2002) 1.17
Laparoscopic versus open myomectomy--a meta-analysis of randomized controlled trials. Eur J Obstet Gynecol Reprod Biol (2009) 1.17
Complement factor H genotypes impact risk of age-related macular degeneration by interaction with oxidized phospholipids. Proc Natl Acad Sci U S A (2012) 1.16
HIV long-term non-progressors maintain brisk CD8 T cell responses to other viral antigens. AIDS (2002) 1.15
Sexual activity and function in postmenopausal women with heart disease. Obstet Gynecol (2005) 1.14
Prevalence of herpes and respiratory viruses in induced sputum among hospitalized children with non typical bacterial community-acquired pneumonia. PLoS One (2013) 1.13
Cutting edge: Receptors for C3a and C5a modulate stability of alloantigen-reactive induced regulatory T cells. J Immunol (2013) 1.13